Abstract
Despite use of computed tomography, some lung cancer patients are found to have unresectable disease at surgery, or they present early with metastases. We studied whether whole-body -positron emission tomography (PET) with F-18-fluorodeoxyglucose ((18)FDG) would improve the preoperative detection of metastases. We retrospectively analysed 34 patients with ''operable'' non-small-cell lung cancer who underwent (18)FDG PET after routine assessment. Management changes produced by the PET scan and confirmatory tests were reviewed. PET unsuspected malignant lesions in 10 (29%) Management changes occurred in 14 (41%), including 6 (18%) patients who were changed to non-surgical therapy. These data suggest that whole-body (18)FDG PET improves preoperative assessment of lung cancer patients.
| Original language | English |
|---|---|
| Pages (from-to) | 1265-1266 |
| Number of pages | 2 |
| Journal | The Lancet |
| Volume | 344 |
| Issue number | 8932 |
| DOIs | |
| Publication status | Published - 5 Nov 1994 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver